Analysis on the application of Chinese medicine injections for activating blood and resolving stasis used in hospitalized patients in one hospital from 2014 to 2016
CUI Hongjiang1 CHEN Jiaxing1 ZHANG Xiaoli1 LI Huifang2
1.Department of Pharmacy, the Second Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Huhhot 010010, China; 2.Department of Pharmacy, the Affiliated Hospital of Inner Mongolia Medical University Pharmacy, Inner Mongolia Autonomous Region, Huhhot 010050, China
Abstract:Objective To study the use of Chinese medicine injections for activating blood and resolving stasis in one hospital for nearly three years, in order to provide reference for clinical rational drug use. Methods The number of varieties and data of the annual sales volume, the frequency of drug use, the sorting ratio and the limited daily expenses of Chinese medicine injections for activating blood and resolving stasis in the Second Affiliated Hospital of Inner Mongolia Medical University from 2014 to 2016 were collected and retrospectively analysed, and the rationality of the medicine was evaluated comprehensively. Results From 2014 to 2016, the number of varieties and annual sales of Chinese medicine injections for activating blood and resolving stasis decreased year by year. The sales volume was decreased by 8.14% and 27.64% respectively in 2015 and 2016, compared with the previous year. The annual sales amount accounted for the total sales amount 16.13%, 14.95% and 12.25%, respectively. Conclusion The medical institutions should continue to regulate the clinical application of Chinese medicine injections for activating blood and resolving stasis. Physicians should strictly follow the instructions to avoid the occurrence of related adverse reactions.
崔鸿江1 陈佳星1 张晓丽1 李慧芳2. 某院2014~2016年住院患者活血化瘀类中药注射剂应用分析[J]. 中国医药导报, 2017, 14(33): 161-164.
CUI Hongjiang1 CHEN Jiaxing1 ZHANG Xiaoli1 LI Huifang2. Analysis on the application of Chinese medicine injections for activating blood and resolving stasis used in hospitalized patients in one hospital from 2014 to 2016. 中国医药导报, 2017, 14(33): 161-164.